Kymera Therapeutics Statistics
Total Valuation
KYMR has a market cap or net worth of $2.38 billion. The enterprise value is $1.56 billion.
Important Dates
The next confirmed earnings date is Thursday, February 27, 2025, before market open.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KYMR has 64.77 million shares outstanding. The number of shares has increased by 19.60% in one year.
| Current Share Class | 64.77M |
| Shares Outstanding | 64.77M |
| Shares Change (YoY) | +19.60% |
| Shares Change (QoQ) | +4.20% |
| Owned by Insiders (%) | 1.33% |
| Owned by Institutions (%) | 76.52% |
| Float | 42.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 29.27 |
| Forward PS | 42.85 |
| PB Ratio | 2.67 |
| P/TBV Ratio | 2.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.55, with a Debt / Equity ratio of 0.10.
| Current Ratio | 8.55 |
| Quick Ratio | 8.29 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -806.89 |
Financial Efficiency
Return on equity (ROE) is -26.00% and return on invested capital (ROIC) is -16.75%.
| Return on Equity (ROE) | -26.00% |
| Return on Assets (ROA) | -15.38% |
| Return on Invested Capital (ROIC) | -16.75% |
| Return on Capital Employed (ROCE) | -20.17% |
| Revenue Per Employee | $468,251 |
| Profits Per Employee | -$895,583 |
| Employee Count | 187 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.21% in the last 52 weeks. The beta is 2.19, so KYMR's price volatility has been higher than the market average.
| Beta (5Y) | 2.19 |
| 52-Week Price Change | -3.21% |
| 50-Day Moving Average | 40.15 |
| 200-Day Moving Average | 41.75 |
| Relative Strength Index (RSI) | 42.52 |
| Average Volume (20 Days) | 466,054 |
Short Selling Information
The latest short interest is 7.69 million, so 11.87% of the outstanding shares have been sold short.
| Short Interest | 7.69M |
| Short Previous Month | 8.35M |
| Short % of Shares Out | 11.87% |
| Short % of Float | 18.01% |
| Short Ratio (days to cover) | 14.94 |
Income Statement
In the last 12 months, KYMR had revenue of $87.56 million and -$167.47 million in losses. Loss per share was -$2.41.
| Revenue | 87.56M |
| Gross Profit | -133.84M |
| Operating Income | -195.27M |
| Pretax Income | -157.85M |
| Net Income | -167.47M |
| EBITDA | -190.49M |
| EBIT | -195.27M |
| Loss Per Share | -$2.41 |
Full Income StatementBalance Sheet
The company has $549.97 million in cash and $88.23 million in debt, giving a net cash position of $822.77 million or $12.70 per share.
| Cash & Cash Equivalents | 549.97M |
| Total Debt | 88.23M |
| Net Cash | 822.77M |
| Net Cash Per Share | $12.70 |
| Equity (Book Value) | 892.93M |
| Book Value Per Share | 13.79 |
| Working Capital | 502.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$124.67 million and capital expenditures -$23.53 million, giving a free cash flow of -$148.20 million.
| Operating Cash Flow | -124.67M |
| Capital Expenditures | -23.53M |
| Free Cash Flow | -148.20M |
| FCF Per Share | -$2.29 |
Full Cash Flow StatementMargins
Gross margin is -152.85%, with operating and profit margins of -223.00% and -191.26%.
| Gross Margin | -152.85% |
| Operating Margin | -223.00% |
| Pretax Margin | -191.26% |
| Profit Margin | -191.26% |
| EBITDA Margin | -217.55% |
| EBIT Margin | -223.00% |
| FCF Margin | n/a |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.60% |
| Shareholder Yield | -19.60% |
| Earnings Yield | -7.02% |
| FCF Yield | -6.22% |
Dividend DetailsAnalyst Forecast
The average price target for KYMR is $55.27, which is 50.15% higher than the current price. The consensus rating is "Buy".
| Price Target | $55.27 |
| Price Target Difference | 50.15% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 37.05% |
| EPS Growth Forecast (5Y) | -1.58% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KYMR has an Altman Z-Score of 7.61 and a Piotroski F-Score of 4.
| Altman Z-Score | 7.61 |
| Piotroski F-Score | 4 |